'Rejuvenation' protects neurons in mouse models of Parkinson's disease (Q28305585)

2

0 references

Ema Ilijic

3

0 references

Jeff N Mercer

4

0 references

Caroline Rick

5

0 references

Tatiana Tkatch

6

0 references

Gloria E Meredith

7

0 references

D James Surmeier

Stages in the development of Parkinson's disease-related pathology

8

0 references

language of work or name

English

0 references

publication date

28 June 2007

0 references

published in

Nature

0 references

volume

447

0 references

page(s)

1081-6

0 references

issue

7148

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Time course of nigrostriatal degeneration in parkinson's disease. A detailed study of influential factors in human brain amine analysis

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Expanding insights of mitochondrial dysfunction in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

The role of mitochondria in inherited neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Origin and functional consequences of the complex I defect in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Molecular Pathways of Neurodegeneration in Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Biomedicine. Parkinson's--divergent causes, convergent mechanisms.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Dopamine depletion does not protect against acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Does levodopa slow or hasten the rate of progression of Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Effects of dihydropyridine calcium antagonists on rat midbrain dopaminergic neurones

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Nifedipine blocks apamin-induced bursting activity in nigral dopamine-containing neurons.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Neuronal Ca(V)1.3alpha(1) L-type channels activate at relatively hyperpolarized membrane potentials and are incompletely inhibited by dihydropyridines

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

G-protein-coupled receptor modulation of striatal CaV1.3 L-type Ca2+ channels is dependent on a Shank-binding domain.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

alpha 1D (Cav1.3) subunits can form l-type Ca2+ channels activating at negative voltages

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Autonomous pacemakers in the basal ganglia: who needs excitatory synapses anyway?

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Pacemaking by HCN channels requires interaction with phosphoinositides.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

I(h) channels contribute to the different functional properties of identified dopaminergic subpopulations in the midbrain.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Excitotoxicity and nitric oxide in Parkinson's disease pathogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Oxidative stress, glutamate, and neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Mitochondria, Ca2+ and neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Physiology and pathophysiology of the calcium store in the endoplasmic reticulum of neurons

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Parkinson's disease: mechanisms and models

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Enhanced sensitivity of dopaminergic neurons to rotenone-induced toxicity with aging

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Activation of group III metabotropic glutamate receptors attenuates rotenone toxicity on dopaminergic neurons through a microtubule-dependent mechanism.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Mitochondrial complex inhibitors preferentially damage substantia nigra dopamine neurons in rat brain slices

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Coupled oscillator model of the dopaminergic neuron of the substantia nigra

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Regulation of cell death: the calcium-apoptosis link

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Identification of mitochondrial DNA polymorphisms that alter mitochondrial matrix pH and intracellular calcium dynamics

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Intraputamenal infusion of GDNF in aged rhesus monkeys: Distribution and dopaminergic effects

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Axon degeneration mechanisms: commonality amid diversity

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Pretreatment with nimodipine prevents MPTP-induced neurotoxicity at the nigral, but not at the striatal level in mice

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Cardiovascular effects of isradipine in essential hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Treatment advances for cocaine-induced ischemic stroke: focus on dihydropyridine-class calcium channel antagonists

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Can calcium antagonists provide a neuroprotective effect in Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

HCN2 and HCN1 channels govern the regularity of autonomous pacemaking and synaptic resetting in globus pallidus neurons.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

High-performance liquid chromatography/tandem mass spectrometry assay for the determination of 1-methyl-4-phenyl pyridinium (MPP+) in brain tissue homogenates

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Midbrain dopaminergic neurons in the mouse: computer-assisted mapping

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

The control of firing pattern in nigral dopamine neurons: single spike firing

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Morphology and electrophysiological properties of immunocytochemically identified rat dopamine neurons recorded in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Electrophysiology of dopaminergic and non-dopaminergic neurones of the guinea-pig substantia nigra pars compacta in vitro

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

D2 dopamine receptor-mediated modulation of voltage-dependent Na+ channels reduces autonomous activity in striatal cholinergic interneurons.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Basal forebrain neurons adjacent to the globus pallidus co-express GABAergic and cholinergic marker mRNAs

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Somatodendritic depolarization-activated potassium currents in rat neostriatal cholinergic interneurons are predominantly of the A type and attributable to coexpression of Kv4.2 and Kv4.1 subunits.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Coordinated Expression of Dopamine Receptors in Neostriatal Medium Spiny Neurons

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Behavioral models of Parkinson's disease in rodents: a new look at an old problem

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

NEURON: a tool for neuroscientists

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Computer simulations of morphologically reconstructed CA3 hippocampal neurons

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Activity-dependent regulation of HCN pacemaker channels by cyclic AMP: signaling through dynamic allosteric coupling

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Cholinergic suppression of KCNQ channel currents enhances excitability of striatal medium spiny neurons.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05865

7 January 2021

Identifiers

DOI

10.1038/NATURE05865

1 reference

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

1574856

1047713730

0 references

1574856

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference